Breaking News Instant updates and real-time market news.

HLT

Hilton

$93.92 /

+0.34 (+0.36%)

, MAR

Marriott

$131.50 /

-0.18 (-0.14%)

10:21
09/11/19
09/11
10:21
09/11/19
10:21

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hilton (HLT) initiated with an Outperform at Bernstein while Marriott (MAR) initiated with a Market Perform. 2. Ceridian (CDAY) initiated with an Overweight at Cantor Fitzgerald. 3. PacifiCare (PHS) initiated with an Outperform at William Blair. 4. Ollie's Bargain Outlet (OLLI) initiated with a Buy at Craig-Hallum. 5. ADP (ADP) initiated with an Outperform at Cowen while Paychex (PAYX) initiated with a Market Perform. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

HLT

Hilton

$93.92 /

+0.34 (+0.36%)

MAR

Marriott

$131.50 /

-0.18 (-0.14%)

CDAY

Ceridian

$51.97 /

+0.22 (+0.43%)

PHS

PacifiCare

$0.00 /

+ (+0.00%)

OLLI

Ollie's Bargain Outlet

$65.17 /

+1.01 (+1.57%)

PAYX

Paychex

$80.71 /

+0.01 (+0.01%)

ADP

ADP

$162.79 /

-1.56 (-0.95%)

  • 12

    Sep

  • 13

    Sep

  • 23

    Sep

  • 24

    Sep

  • 02

    Oct

HLT Hilton
$93.92 /

+0.34 (+0.36%)

09/11/19 Bernstein
Bernstein bullish on Hilton, initiates with an Outperform
09/10/19 Bernstein
Hilton initiated with an Outperform at Bernstein
09/03/19
Fly Intel: Top five analyst downgrades
09/03/19 Macquarie
Macquarie downgrades Hilton to Neutral, sees positives as priced in
MAR Marriott
$131.50 /

-0.18 (-0.14%)

09/11/19 Bernstein
Bernstein bullish on Marriott, initiates with an Outperform
09/10/19 Bernstein
Marriott initiated with a Market Perform at Bernstein
08/06/19 Jefferies
Marriott results to pressure shares near-term, says Jefferies
07/17/19 BofA
Pebblebrook Hotel downgraded to Neutral from Buy at BofA/Merrill
CDAY Ceridian
$51.97 /

+0.22 (+0.43%)

09/11/19 Cantor Fitzgerald
Cantor Fitzgerald stars Ceridian at Overweight, sees upside to esimates
09/10/19 Cantor Fitzgerald
Ceridian initiated with an Overweight at Cantor Fitzgerald
09/06/19 Mizuho
Ceridian recent selloff brings buying opportunity, says Mizuho
08/22/19
Ceridian initiated with a Buy at Mizuho
PHS PacifiCare
$0.00 /

+ (+0.00%)

09/11/19 William Blair
PacifiCare initiated with an Outperform at William Blair
OLLI Ollie's Bargain Outlet
$65.17 /

+1.01 (+1.57%)

09/11/19 Craig-Hallum
Ollie's Bargain Outlet initiated with a Buy at Craig-Hallum
08/29/19 Wells Fargo
Ollie's Bargain Outlet price target lowered to $60 from $85 at Wells Fargo
08/29/19 JPMorgan
Ollie's Bargain Outlet earnings pullback a buying opportunity, says JPMorgan
08/29/19 Loop Capital
Ollie's Bargain Outlet price target lowered to $75 from $100 at Loop Capital
PAYX Paychex
$80.71 /

+0.01 (+0.01%)

09/11/19 Cowen
Paychex initiated with a Market Perform at Cowen
08/15/19 Morgan Stanley
Paychex cut to Underweight at Morgan Stanley on SMID business weakening
06/26/19
Paychex downgraded to Underperform on valuation at BofA/Merrill
06/26/19 BofA
Paychex downgraded to Underperform from Neutral at BofA/Merrill
ADP ADP
$162.79 /

-1.56 (-0.95%)

09/11/19 BofA
ADP downgraded to Neutral from Buy at BofA/Merrill
09/11/19 Cowen
ADP initiated with an Outperform at Cowen
07/31/19 Jefferies
ADP price target raised to $176 from $167 at Jefferies

TODAY'S FREE FLY STORIES

Earnings
Opera reports Q4 adj. EPS 20c, two est. 9c » 07:52
02/25/20
02/25
07:52
02/25/20
07:52
OPRA

Opera

$7.14 /

+0.275 (+4.01%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Cantor reiterates Overweight rating on Theravance into 'big year' » 07:51
02/25/20
02/25
07:51
02/25/20
07:51
TBPH

Theravance Biopharma

$23.51 /

-2.2 (-8.56%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Dine Brands downgraded to Neutral from Buy at MKM Partners » 07:50
02/25/20
02/25
07:50
02/25/20
07:50
DIN

Dine Brands

$96.06 /

-1.13 (-1.16%)

MKM Partners analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Xencor upgraded to Buy from Neutral at Guggenheim » 07:50
02/25/20
02/25
07:50
02/25/20
07:50
XNCR

Xencor

$33.21 /

-1.93 (-5.49%)

Guggenheim analyst Etzer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
NIO Inc. announces framework agreement with Hefei Municipal Government » 07:49
02/25/20
02/25
07:49
02/25/20
07:49
NIO

NIO Inc.

$3.88 /

-0.195 (-4.79%)

NIO announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Galapagos downgraded to Neutral on valuation at Cantor Fitzgerald » 07:49
02/25/20
02/25
07:49
02/25/20
07:49
GLPG

Galapagos

$245.02 /

-28.77 (-10.51%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Palo Alto Networks price target lowered to $190 from $195 at Credit Suisse » 07:48
02/25/20
02/25
07:48
02/25/20
07:48
PANW

Palo Alto Networks

$236.99 /

-5.87 (-2.42%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Corvus Gold receives results from Main Zone infill, step-out Phase-4 program » 07:48
02/25/20
02/25
07:48
02/25/20
07:48
CORVF

Corvus Gold

$0.00 /

+ (+0.00%)

Corvus Gold announces it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Tandem Diabetes price target raised to $90 from $85 at Cowen » 07:47
02/25/20
02/25
07:47
02/25/20
07:47
TNDM

TNDM

/

+

Cowen analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Arcutis Biotherapeutics initiated with an Overweight at Cantor Fitzgerald » 07:46
02/25/20
02/25
07:46
02/25/20
07:46
ARQT

Arcutis Biotherapeutics

$28.04 /

+1.035 (+3.83%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
BioCryst appoints Alan Levin to board of directors » 07:45
02/25/20
02/25
07:45
02/25/20
07:45
BCRX

BioCryst

$2.40 /

-0.15 (-5.88%)

, PFE

Pfizer

$34.68 /

-1.03 (-2.88%)

, ENDP

Endo

$6.02 /

-0.065 (-1.07%)

BioCryst Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Medpace price target raised to $99 from $91 at Credit Suisse » 07:45
02/25/20
02/25
07:45
02/25/20
07:45
MEDP

Medpace

$98.83 /

-0.76 (-0.76%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Strongbridge expects to report top-line results from LOGICS study in Q2 or Q3 » 07:44
02/25/20
02/25
07:44
02/25/20
07:44
SBBP

Strongbridge Biopharma

$3.08 /

-0.17 (-5.23%)

Enrollment in the Phase 3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Citigroup to hold a conference » 07:43
02/25/20
02/25
07:43
02/25/20
07:43
CBOE

Cboe Global Markets

$121.98 /

-1.27 (-1.03%)

, RMR

RMR Group

$40.59 /

-1.63 (-3.86%)

2020 Asset Managers,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Apple consensus estimates too high, says Cowen » 07:43
02/25/20
02/25
07:43
02/25/20
07:43
AAPL

Apple

$298.16 /

-14.86 (-4.75%)

Cowen analyst Krish…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Strongbridge Biopharma expects cash to fund operations through 3Q21 » 07:43
02/25/20
02/25
07:43
02/25/20
07:43
SBBP

Strongbridge Biopharma

$3.08 /

-0.17 (-5.23%)

Strongbridge had $78…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Strongbridge Biopharma sees FY20 KEVEYIS revenue $26M-$27M » 07:43
02/25/20
02/25
07:43
02/25/20
07:43
SBBP

Strongbridge Biopharma

$3.08 /

-0.17 (-5.23%)

The Company continues to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
EverQuote price target raised to $49 from $30 at Raymond James » 07:42
02/25/20
02/25
07:42
02/25/20
07:42
EVER

EverQuote

$45.76 /

-0.83 (-1.78%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Intuit price target raised to $310 from $300 at Credit Suisse » 07:42
02/25/20
02/25
07:42
02/25/20
07:42
INTU

Intuit

$286.50 /

-11.27 (-3.78%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Strongbridge Biopharma reports Q4 adj. EPS (25c), consensus (26c) » 07:42
02/25/20
02/25
07:42
02/25/20
07:42
SBBP

Strongbridge Biopharma

$3.08 /

-0.17 (-5.23%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Trex Company downgraded to Neutral from Buy at DA Davidson » 07:41
02/25/20
02/25
07:41
02/25/20
07:41
TREX

Trex Company

$102.98 /

-3.27 (-3.08%)

DA Davidson analyst Kurt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Apple institutional ownership at highest level since 2012, says Morgan Stanley » 07:41
02/25/20
02/25
07:41
02/25/20
07:41
AAPL

Apple

$298.16 /

-14.86 (-4.75%)

, AMZN

Amazon.com

$2,009.74 /

-84.55 (-4.04%)

, FB

Facebook

$200.77 /

-9.34 (-4.45%)

, GOOGL

Alphabet Class A

$1,420.45 /

-62.39 (-4.21%)

, GOOG

Alphabet

$1,422.89 /

-61.38 (-4.14%)

Morgan Stanley analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
FTI Consulting sees 2020 adj. EPS $5.50-$6.00, consensus $5.73 » 07:40
02/25/20
02/25
07:40
02/25/20
07:40
FCN

FTI Consulting

$118.06 /

-5.83 (-4.71%)

The Company estimates…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Treasury Market Outlook: a bounce in risk appetite helped U.S. equity futures recover » 07:40
02/25/20
02/25
07:40
02/25/20
07:40

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Palo Alto Networks downgraded to Neutral from Overweight at JPMorgan » 07:39
02/25/20
02/25
07:39
02/25/20
07:39
PANW

Palo Alto Networks

$236.99 /

-5.87 (-2.42%)

JPMorgan analyst Sterling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.